H.R. 5663 · 116th Congress

Safeguarding Therapeutics Act

Stage: Signed by the president
Sponsor: Brett Guthrie
Introduced: 2020-01-21
Latest action: 2021-01-05 · Signed by President.

Action history

2021-01-05Signed by President.
2021-01-05Became Public Law No: 116-304.
2020-12-24Presented to President.
2020-12-10Motion to reconsider laid on the table Agreed to without objection.
2020-12-10On motion that the House agree to the Senate amendment Agreed to without objection.
2020-12-10Mrs. Dingell asked unanimous consent to take the bill, H.R. 5663 from the Speaker's Table and agree to the Senate amendment.
2020-12-10Mrs. Dingell asked unanimous consent that the House agree to the Senate amendment.
2020-12-09Message on Senate action sent to the House.
2020-12-08Passed Senate with an amendment by Unanimous Consent.
2020-12-08Measure laid before Senate by unanimous consent.
2020-12-08Senate Committee on Health, Education, Labor, and Pensions discharged by Unanimous Consent.
2020-09-22Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
2020-09-21Motion to reconsider laid on the table Agreed to without objection.
2020-09-21On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.
2020-09-21DEBATE - The House proceeded with forty minutes of debate on H.R. 5663.
2020-09-21Considered under suspension of the rules.
2020-09-21Mrs. Dingell moved to suspend the rules and pass the bill, as amended.
2020-09-17Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-512.
2020-09-17Placed on the Union Calendar, Calendar No. 412.
2020-07-15Committee Consideration and Mark-up Session Held.
2020-07-15Ordered to be Reported (Amended) by Voice Vote.
2020-03-11Ordered to be Reported by Voice Vote.
2020-03-11Subcommittee Consideration and Mark-up Session Held.
2020-01-22Referred to the Subcommittee on Health.
2020-01-21Introduced in House